Препараты От Склероза

China Formally Arrests Japanese Employee of Dru...

Astellas Home page | Astellas Pharma Inc.

Astellas Pharma EMEA celebrates its 10th annive...

Astellas, University of Tokyo extend partnershi...

Astellas introduces sustainable community initi...

Astellas

Asia Business Daily on Twitter: "Astellas Pharm...

Astellas Home page | Astellas Pharma Inc.

US FDA approves Astellas Pharma pill for menopa...

Главная | Astellas Pharma Russia

Astellas Pharma: A Contrarian Investment (OTCMK...

Astellas Offloads 5 Legacy Products to Germany’...

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Astellas Sues Over New Myrbetriq Patent to Reca...

Astellas Pharma - Global Web Site on Behance

Атлас лекарственных растений - YouTube

Astellas Pharma to acquire Propella Therapeutic...

FDA Grants Full Approval for Astellas Pharma's ...

Astellas gets FDA priority review for gastric c...

Pharmaceutical Technology

Astellas Pharma Inc. (4503N.MX) stock price, ne...

Astellas Pharma

Astellas Pharma Projects :: Photos, videos, log...

Astellas Pharmaceuticals Establishes Open Innov...

Astellas' Prostate Cancer Drug Available In Jap...

Astellas licenses 4DMT’s AAV vector for ophthal...

Home | Astellas Pharma Canada, Inc.

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Astellas Pharma Joins Record Bond Sales by Japa...

FDA Approves Astellas’ Non-hormonal Menopause T...

Главная | Astellas Pharma Russia

About | Astellas Pharma Ltd

FDA blocks Astellas’ Claudin cancer drug over m...

Japan's Astellas sees cancer drug fueling 29% p...